Toshiba Medical Systems

AHA SCIENTIFIC SESSIONS

American Heart AssociationCardiovascular Business presents the latest developments and announcements at the 2008 Scientific Sessions of the American Heart Association in New Orleans.

Go to AHA 360 Coverage >

TCT 360˚

TCT 360TCT 360˚ Complete Conference Coverage
In-depth coverage of the 20th Transcathether Cardiovascular Therapeutics Conference in Washington, DC
October 12-17, 2008

Visit TCT 360˚ >

PORTALS

Advanced Visualization

More Advanced Visualization news...

Cardiac Imaging

More Cardiac Imaging news...

TOP STORIES

St. Jude buys two CV medical device makers for $550M

Tue, Dec 23 2008
 
St. Jude Medical has completed its acquisition of Radi Medical Systems for $250 million in cash and MediGuide, including the 41.3 percent interest owned by Elbit Systems, for $283 million in cash and the assumption of net liabilities totaling approximately $17 million.

Emageon demands that HSS merger is finalized by today

Tue, Dec 23 2008
 
Emageon has formally demanded a closing of its pending merger with Health Systems Solutions (HSS) by today, Dec. 23.

Jury still out in case of fraudulent cardiologist

Tue, Dec 23 2008
 
Jury deliberations continued for the fourth day on Monday with no verdict in the federal healthcare fraud trial of Louisiana cardiologist, Mehmood M. Patel, MD, who is accused of billing the government and private insurers more than $2 million for unnecessary heart procedures from 2001 to 2004.

CMAJ: DES might only best BMS in the short term

Tue, Dec 23 2008
 
Patients receiving drug-eluting stents (DES), as part of an angioplasty, had better outcomes one year later than patients with bare-metal stents (BMS), according to a prospective study published as an early release Dec. 18 in the Canadian Medical Association Journal.
Latest News

Commonwealth Fund launches hospital ratings site

Industry News | Tue, Dec 23 2008
The Commonwealth Fund has launched a new web resource at the Institute for Healthcare Improvement's National Forum, in Nashville, La., which will make public the competing hospital quality ratings systems.

CHMP gives thumbs up for prasugrel

Industry News | Tue, Dec 23 2008
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of prasugrel from Daiichi Sankyo and Eli Lilly for the prevention of atherothrombotic events in patients with acute coronary syndromes undergoing PCI.

Two Illinois hospitals align for improved cardiovascular care

Industry News | Tue, Dec 23 2008
St. John’s Hospital’s parent organization has launched a joint partnership with Prairie Cardiovascular physician group as part of a “care integration” project to provide higher-quality services for patients and reduce waste.

GlaxoSmithKline commences large-scale heart drug trial

Industry News | Mon, Dec 22 2008
GlaxoSmithKline (GSK) has initiated the first pivotal Phase III clinical trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with chronic coronary heart disease (CHD).

Abbott launches trial to evaluate Xience in 2.25 vessel size

Industry News | Mon, Dec 22 2008
Abbott Vascular has begun SPIRIT Small Vessel, a clinical trial evaluating a 2.25 mm version of its Xience V everolimus-eluting coronary stent system.

CRF launches women cardiology research fellowship

Industry News | Mon, Dec 22 2008
The Women's Heart Health Initiative at the Cardiovascular Research Foundation (CRF) has created a new fellowship dedicated to gender-specific research that will seek to improve the prevention, diagnosis and treatment of heart disease in women.

NEJM: Intensive glucose control fails to reduce cardiovascular events

Clinical Studies | Mon, Dec 22 2008
Intensive glucose control in patients with poorly controlled type 2 diabetes had no significant effect on the rates of major cardiovascular events, death or microvascular complications, according to a study in the Dec. 17 issue of the New England Journal of Medicine.

JAMA: Longer sleep duration linked with less of calcification in coronary arteries

Clinical Studies | Mon, Dec 22 2008
Study participants who slept on average an hour longer per night than other participants had an associated lower incidence of coronary artery calcification, according to research published in the Dec. 24/31 issue of Journal of the American Medical Association.

AJC: Patients with severe psoriasis need evaluation of heart disease risk

Clinical Studies | Mon, Dec 22 2008
Patients with severe forms of the skin disease psoriasis should receive evaluation and possible treatment to reduce their risk of coronary artery disease (CAD), according to new recommendations in the Dec. 10 issue of the American Journal of Cardiology.

FDA greenlights Epix blood pool MRA agent

Regulatory News | Mon, Dec 22 2008
The FDA has approved for marketing Epix Pharmaceuticals blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease.

Most read articles in the past 30 days